Last updated on November 2017

Obsessive-Compulsive Disorder


Brief description of study

Male and female outpatient subjects between the ages of 18 - 65 years, inclusive, with a primary DSM-V diagnosis of Obsessive Compulsive Disorder who have had an inadequate response to Standard of Care medications.

Eligibility Criteria:

It is required that all women of child-bearing potential (WOCBP) who are sexually active agree to use two methods of contraception for the duration of the study (i.e. beginning 30 days prior to baseline and extending to 30 days after the last dose of study drug). The two methods should include:
1. one barrier method (e.g. diaphragm with spermicide, condom with spermicidal gel, intrauterine devices, cervical cap);
2. and one other method. The other method could include oral contraceptives or another barrier method (Section 5.2.4.2)

Clinical Study Identifier: TX133680

Find a site near you

Start Over

Northwest Clinical Research Center

1951 152nd Pl NE Suite 200 Bellevue, WA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.